RASSF1A: A promising target for the diagnosis and treatment of cancer
- 23 January 2020
- journal article
- review article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 504, 98-108
- https://doi.org/10.1016/j.cca.2020.01.014
Abstract
No abstract availableKeywords
Funding Information
- Hunan Provincial Innovation Foundation for Postgraduate, China (CX20190766)
- Natural Science Foundation of Hunan Province (2018JJ2356, 2019JJ80034)
This publication has 168 references indexed in Scilit:
- Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cellsMolecular Cancer, 2013
- Outcomes of Screening Mammography by Frequency, Breast Density, and Postmenopausal Hormone TherapyJAMA Internal Medicine, 2013
- Loss of RASSF1A Expression in Colorectal Cancer and Its Association with K-ras StatusBioMed Research International, 2013
- The Prognostic Role of RASSF1A Promoter Methylation in Breast Cancer: A Meta-Analysis of Published DataPLOS ONE, 2012
- RASSF1A and the Taxol Response in Ovarian CancerMolecular Biology International, 2012
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningThe New England Journal of Medicine, 2011
- Management of hepatocellular carcinoma: An updateJournal of Hepatology, 2011
- High-Definition DNA Methylation Profiles from Breast and Ovarian Carcinoma Cell Lines with Differing Doxorubicin ResistancePLOS ONE, 2010
- Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesionsHuman Pathology, 2009
- RASSF1A Elicits Apoptosis through an MST2 Pathway Directing Proapoptotic Transcription by the p73 Tumor Suppressor ProteinMolecular Cell, 2007